The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Effects of docetaxel on circulating immune cell subsets and association with outcomes in metastatic castration-sensitive prostate cancer.
 
Elias Chandran
Stock and Other Ownership Interests - Pacific Edge Biotechnology
 
Meghali Goswami
No Relationships to Disclose
 
Renee Nicole Donahue
No Relationships to Disclose
 
Mohammad O. Atiq
Travel, Accommodations, Expenses - Agios; Alnylam (I); Astellas Pharma; AstraZeneca (I); Celgene; Daiichi Sankyo Inc. (I); Foundation Medicine (I); Genentech (I); Gilead Sciences (I); Incyte; Jazz Pharmaceuticals; Pfizer; Pfizer (I); Rigel; Rigel
 
Fatima Karzai
No Relationships to Disclose
 
Marijo Bilusic
Research Funding - Bavarian Nordic (Inst); ImmunityBio (Inst); Merck (Inst); NextCure (Inst); Surface Oncology (Inst)
 
Jennifer L. Marte
No Relationships to Disclose
 
Philip M. Arlen
No Relationships to Disclose
 
Lisa M. Cordes
No Relationships to Disclose
 
Helen Owens
No Relationships to Disclose
 
Megan Hausler
No Relationships to Disclose
 
Amy Hankin
Stock and Other Ownership Interests - Amgen; Medtronic
 
Monique Williams
No Relationships to Disclose
 
William L. Dahut
Leadership - Dexcom (I)
Stock and Other Ownership Interests - Dexcom (I)
 
William Douglas Figg
Research Funding - Astellas Pharma (Inst); Biocompatibles (Inst); Celgene (Inst); Nerviano Medical Sciences (Inst); NovaRX (Inst); Pfizer (Inst); Propella Therapeutics (Inst); TRACON Pharma (Inst)
 
Jeffrey Schlom
No Relationships to Disclose
 
James L. Gulley
Research Funding - Astellas Medivation (Inst); Bavarian Nordic (Inst); Bristol-Myers Squibb (Inst); EMD Serono (Inst); ImmunityBio (Inst); Incyte (Inst); Janssen Oncology (Inst); Merck (Inst); Pfizer (Inst)
Patents, Royalties, Other Intellectual Property - COMBINATION PDL1 AND TGF-BETA BLOCKADE IN PATIENTS WITH HPV+ MALIGNANCIES Publication number: 20200062849 Abstract: The invention provides a method of inhibiting a malignancy associated with human papilloma virus (HPV) comprising administering to a subje
 
Ravi Amrit Madan
Speakers' Bureau - Boehringer Ingelheim (I); Janssen (I); Pfizer (I)
Research Funding - Bayer